Related Experiment Videos
Vascular mechanisms in osteoarthritis
1Institute of Bone and Joint Research, Department of Surgery, University of Sydney, Level 5, University Clinic, Royal North Shore Hospital, St Leonards, NSW, 2065, Australia.
Best Practice & Research. Clinical Rheumatology
|January 29, 2002
Summary
Osteoarthritis (OA) progression involves cartilage breakdown, synovitis, and bone abnormalities. Targeting inflammation and coagulation may offer new OA treatments.
Area of Science:
- Biomedical Science
- Rheumatology
- Pathology
Background:
- Articular cartilage damage from various factors may not cause pain initially.
- Osteoarthritis (OA) involves cartilage failure, synovitis, and subchondral bone abnormalities, typically causing pain.
Purpose of the Study:
- To propose a hypothesis on OA pathogenesis, linking cartilage fibrillation to synovitis via cartilage-derived antigens.
- To suggest novel therapeutic strategies for OA based on the proposed mechanism.
Main Methods:
- Review of existing literature and pathological processes in OA.
- Formulation of a hypothesis on the inflammatory and thrombotic cascade in OA progression.
- Description of experimental studies supporting the proposed therapeutic approach.
Main Results:
- Cartilage fibrillation releases antigens, activating macrophages and leukocytes, leading to synovitis.
- Synovitis perpetuates cartilage destruction and promotes hypercoagulation, hypofibrinolysis, and thrombosis.
- Ageing and hormonal changes exacerbate these pathological events.
Conclusions:
- OA progression is driven by an inflammatory and thrombotic process initiated by cartilage damage.
- Anti-thrombotic and anti-lipidaemic agents with anti-inflammatory properties show potential as OA treatments.